Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies
about
Utility of Plasmapheresis in Autoimmune-Mediated Encephalopathy in Children: Potentials and ChallengesAutoimmune encephalitis in childrenProgressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab.Antibody-Mediated Autoimmune Encephalopathies and ImmunotherapiesAutoimmune encephalopathies.Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-upAnti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilisOvarectomy despite Negative Imaging in Anti-NMDA Receptor Encephalitis: Effective Even Late.Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitisGlutamatergic Mechanisms Associated with Seizures and Epilepsy.Autoimmune encephalitis: Clinical diagnosis versus antibody confirmation.Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy.Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis/New serological markers for the differential diagnosis of autoimmune limbic encephalitis
P2860
Q26865785-CF731587-4EE7-46EE-9502-E18C2CCEFBFBQ27010170-F42275A8-1D38-47E5-A440-005C135436EDQ27323224-7CB8071E-C8FA-42BC-BD16-1C7A0804CFD4Q28084055-66063F74-6927-484D-93DF-D881A4945891Q30389491-211CF636-2A08-4D50-9E98-ADE3E8F8E62CQ33551430-974F729A-F2B2-4771-AD8A-8ED109B82079Q33862239-2CCB8048-D0B4-46C9-A4F2-F06906C34121Q34086135-B6FCE9A4-8C3E-4D5D-88B1-9AD8AE2C5950Q36240987-10838F8C-F783-4868-B92A-9D1DA6A74B90Q36692319-CE2ABFF2-A463-4FB0-A87D-550B572A62D7Q36999071-CD00928A-BF18-429A-9F3F-057D15A8C0D9Q38535033-72E53538-9B38-417E-A9E0-170BC20A1385Q42787178-04393712-7042-45EB-8D0F-EC2AE5C7ADFBQ54207301-2C38F92F-C77E-462F-BF78-5FD59E6B1A88Q57255961-A9331BFC-0305-492E-B24C-6C5F0B6B3CB9
P2860
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies
description
im März 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 08 March 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
Paraneoplastic anti-NMDAR ence ...... ls persistent serum antibodies
@en
Paraneoplastic anti-NMDAR ence ...... ls persistent serum antibodies
@nl
type
label
Paraneoplastic anti-NMDAR ence ...... ls persistent serum antibodies
@en
Paraneoplastic anti-NMDAR ence ...... ls persistent serum antibodies
@nl
prefLabel
Paraneoplastic anti-NMDAR ence ...... ls persistent serum antibodies
@en
Paraneoplastic anti-NMDAR ence ...... ls persistent serum antibodies
@nl
P2860
P1433
P1476
Paraneoplastic anti-NMDAR ence ...... ls persistent serum antibodies
@en
P2093
Marinos C Dalakas
Michalis L Kosmidis
P2860
P2888
P304
P356
10.1007/S00415-011-5982-4
P577
2011-03-08T00:00:00Z